Impact of the Stent Length on Long-Term Clinical Outcomes Following Newer-Generation Drug-Eluting Stent ImplantationIk Jun Choi, Ki‐Bae Seung, Dong Il Shin et al.|The American Journal of Cardiology|2013Cited by 50
Randomized Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stents vs. Sirolimus-Eluting Stents for Percutaneous Coronary Intervention in Chronic Total OcclusionHun‐Jun Park, Ki‐Bae Seung, Hee-Yeol Kim et al.|Circulation Journal|2012Cited by 46
Soluble receptor for advanced glycation end products is associated with in-stent restenosis in patients with type 2 diabetes with drug-eluting coronary stentsHun‐Jun Park, Ki‐Dong Yoo, Suk Min Seo et al.|Coronary Artery Disease|2010Cited by 10
SIROLIMUS ELUTING STENT IS SUPERIOR TO PACLITAXEL ELUTING STENT IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY.Soe Hee Ann, Ki‐Bae Seung, Chan Joon Kim et al.|Journal of the American College of Cardiology|2011Cited by 0
Effect of angiotensin receptor blocker dose in MI with preserved left ventricular systolic functionHee-Yeol Kim, Yongkeun Ahn, Jisu Mok et al.|Journal of Cardiovascular Pharmacology|2023Cited by 0